Organon International
From Wikipedia, the free encyclopedia
Organon International, Inc. is a pharmaceutical company headquartered in Roseland, New Jersey that is part of Akzo Nobel. When the company was first formed it originally maintained its headquarters, research and development and sales offices in three buildings it owned in neighboring West Orange, New Jersey however the company moved out of West Orange citing high property taxes, the buildings were put up for sale however as of this writing there has been no takers and the properties are basically sitting empty and abandoned.
Organon deals in the following core therapeutic fields: reproductive medicine, contraception, psychiatry and anesthesia. Organon sells to international markets.
Organon was founded by Dr.Saal van Zwanenberg in Oss, the Netherlands, in 1923 as Zwanenberg-Organon. Its first product was insulin. In the thirties it manufactured estrogens. The production of cortison was initiated in 1953. The now named Koninklijke Zwanenberg-Organon (KZO) fused with the fiber producer AKU in 1969 to become AKZO, later Akzo Nobel. Organon is the human health care business unit of Akzo Nobel and transferred its headquarters to the USA while the main headquarter of Akzo Nobel remains in Arnhem. Manufacturing facilities are in the Netherlands, Germany, the United Kingdom, China, Japan, and the USA.
